Mobic approved for rheumatoid arthritis
Boehringer Ingelheim's osteoarthritis drug Mobic (meloxicam) adds indication for treatment of rheumatoid arthritis with FDA approval July 16. BI received an action letter for the rheumatoid arthritis indication in December 2001; the company responded in January 2004...
You may also be interested in...
The UK has an “excellent but small diagnostics industry,” so it needs further testing support from related life science industries to tackle the COVID-19 crisis. One of the outcomes of this could be the creation of new big diagnostics industry players.
Medicinal products authorities will consider a medtech notified body opinion on the device element of a drug/device combination product. A new position paper explains how roles and responsibilities are shared between medtech and medicinal product experts.
A South Korean pharma firm is set to soon begin pivotal clinical trials for a hyperimmune globulin for the treatment of COVID-19 patients and plans to commercialize the product this year, with a hope of outrunning rivals including Takeda.